How much revenue does GeneMatrix make?

GeneMatrix reported 10.64 billion KRW in revenue for fiscal year 2025, up 6.2% from 10.02 billion KRW in fiscal year 2024.

What companies are similar to GeneMatrix?

Listed companies of a similar size in the same industry (DNA testing equipment) include Genomictree Inc. (228760.KQ), Gencurix Inc. (229000.KQ), Genesystem Co., Ltd. (363250.KQ), Celestra Inc. (352770.KQ).

GeneMatrix Inc. (109820.KQ) Stock

About GeneMatrix Inc.

GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also p...

At a glance

GeneMatrix reported revenue of 10.64 billion KRW for fiscal year 2025, up 6.2% from fiscal year 2024, and net income of -1.83 billion KRW.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.